for the treatment of large vessel occlusion stroke is well established, but uncertainty remains
around the true cost of delivering this treatment within the NHS. The aim of this study was to
establish the cost of providing MT within the hyperacute phase of care and to explore
differences in resources used and costs across different neuroscience centres in the UK.
Method This was a multicentre retrospective study using micro-costing methods to enable a …